What is NDC 50090-5918?

50090-5918 is the product NDC for Erythromycin, Erythromycin 250 mg/1 tablet, film coated, listed with the FDA by A-S Medication Solutions. It has 2 package NDCs, shown above in 10- and 11-digit form.

A-S Medication Solutions, NDC labeler code 50090. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Erythromycin?

69 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Erythromycin NDC 50090-5918 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)50090-5918Labeler and product segments. Claims need a package NDC.

Product NDC at billing width50090-5918Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
50090-5918-5	50090591805	3 TABLET, FILM COATED in 1 BOTTLE (50090-5918-5)Marketed from Feb 14, 2022
50090-5918-6	50090591806	90 TABLET, FILM COATED in 1 BOTTLE (50090-5918-6)Marketed from Jun 9, 2022

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Erythromycin
Generic name (nonproprietary): erythromycin
Active ingredients: Erythromycin — 250 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: A-S Medication SolutionsNDC labeler code 50090
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 214549
Marketing start: May 4, 2021
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Sebaceous Gland Activity (Physiologic effect)Macrolides (Chemical structure)
Identifiers: Product ID 50090-5918_92c063bb-9f59-40c0-8529-4903e94dfed3SPL ID 92c063bb-9f59-40c0-8529-4903e94dfed3SPL set ID 99eb7dbc-6ba9-4122-ad1e-5cae73186932RxCUI 598006UNII 63937KV33D
Pharmacologic class: Macrolide Antimicrobial; Macrolide

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N450090591805 followed by a unit qualifier and the quantity

Package 50090-5918-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 2, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE To reduce the development of drug-resistant bacteria and maintain the effectiveness of erythromycin tablets and other antibacterial drugs, erythromycin tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Erythromycin tablets are indicated in the treatment of infections caused by susceptible strains of the designated microorganisms …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 50090-5918

What is NDC 50090-5918?: 50090-5918 is the product NDC for Erythromycin, Erythromycin 250 mg/1 tablet, film coated, listed with the FDA by A-S Medication Solutions. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Erythromycin.
What is the active ingredient?: Erythromycin.
Who is the labeler?: A-S Medication Solutions, NDC labeler code 50090. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Erythromycin?: 69 other product NDCs are listed under this name. See all Erythromycin NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Erythromycin NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Erythromycin	Erythromycin 5 mg/g	OintmentOphthalmic	Sentiss Pharmaceuticals LLC	70244-031	70244-0031-0170244-0031-02
Erythromycin	Erythromycin 333 mg/1	Tablet, Delayed releaseOral	Torrent Pharmaceuticals Limited	13668-587	13668-0587-0113668-0587-0513668-0587-30
erythromycin	Erythromycin 250 mg/1	Capsule, Delayed release pelletsOral	Dr. Reddy's Labratories Inc.	75907-076	75907-0076-01
Erythromycin	Erythromycin 5 mg/g	OintmentOphthalmic	NuCare Pharmaceuticals,Inc.	68071-3992	68071-3992-02
Erythromycin	Erythromycin 5 mg/g	OintmentOphthalmic	ARMAS PHARMACEUTICALS INC.	72485-670	72485-0670-3172485-0670-35
Erythromycin	Erythromycin 5 mg/g	OintmentOphthalmic	ST. MARY'S MEDICAL PARK PHARMACY	60760-670	60760-0670-35
Erythromycin	Erythromycin 5 mg/g	OintmentOphthalmic	Redpharm Drug	67296-2128	67296-2128-03
Erythromycin	Erythromycin 5 mg/g	OintmentOphthalmic	Fera Pharmaceuticals, LLC	48102-057	48102-0057-11
Erythromycin	Erythromycin 250 mg/1	Tablet, Film coatedOral	Alembic Pharmaceuticals Limited	46708-397	46708-0397-3046708-0397-3146708-0397-91
Erythromycin	Erythromycin 500 mg/1	Tablet, Film coatedOral	Alembic Pharmaceuticals Limited	46708-398	46708-0398-3046708-0398-3146708-0398-91

All 70 Erythromycin NDCs

Other NDCs under ANDA 214549

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 214549
Product	Strength	Form · route	Labeler	Product NDC
Erythromycin	Erythromycin 250 mg/1	Tablet, Film coatedOral	Teva Pharmaceuticals USA, Inc.	0093-5571
Erythromycin	Erythromycin 500 mg/1	Tablet, Film coatedOral	Teva Pharmaceuticals USA, Inc.	0093-5572